*HGPI published a new report, The Impact of Innovation Across Technology, Health, Care and Urban Design for Super-Ageing Societies. The report offers recommendations on these critical topics to policymakers and other leaders across global society, based on this expert meeting.

More information is available here.

Health and Global Policy Institute (HGPI) and Global Coalition on Aging (GCOA) partnered to hold a joint global expert meeting, “The Impact of Innovation Across Technology, Health, Care and Urban Design for Super Ageing Societies” on November 2, 2018.

As the world’s oldest nation, Japan is the first to face major challenges due to demographic ageing and trends are expected to continue until 2042 according to the Ministry of Health, Labour and Welfare (MHLW). Japan is currently facing tough choices as this shift in society threatens the sustainability of its vaunted universal health system. The future health care system requires a paradigm shift and policy support that would allow Japan to ensure that the Japanese people can keep enjoying longer, healthier, and productive lives, and help Japan to maintain its long-standing position as a global leader in scientific innovation.

Against this backdrop, GCOA and HGPI gathered approximately 30 experts from the public and private sectors of Japan, the United States, and Europe for a discussion aimed at achieving the following objectives:

1. Advance the conversation on driving innovation across four core topics related to super ageing societies:
・Health Innovation for Age Friendly Communities
・21st Century Health Policy for Super Ageing Societies
・Financing Super Ageing Societies
・Partnerships for an Age Friendly World

2. Bring together a unique set of stakeholders across diverse sectors of society to support spending on health as an investment in the light of 21st century longevity; innovation in pharmaceuticals, remote care technology and home care as core components of healthy and active ageing; and incentives aligned to healthier ageing to improve outcomes and reduce costs.

3. Achieve consensus on necessary actions to ensure super ageing societies have opportunities for sustained health, engagement, and productivity through innovative approaches to health, care, technology and urban design:
・Policy reforms enabling innovation for healthier and more active ageing
・Role of Japan as the first super ageing society and model for how to achieve healthy longevity
・Willingness to invest today in order to reduce costs tomorrow

This expert meeting was conducted in a moderated roundtable format. Sessions 1, 2 and 3 were informed by brief (5 minute) presentations from “thought starters” to set the scene and provide context for each topic.

――――
Overview
Welcome Remarks

 Kiyoshi Kurokawa (Chairman, HGPI)

Keynote Remarks: Japan’s Super Ageing Society Today and Tomorrow
 Keisuke Suzuki (State Minister of Finance, Government of Japan)
 Nicholas Hill (Minister Counselor for Economic Affairs, U.S. Embassy Tokyo)
 

Ambassador’s Remarks: The Leadership Imperative to Achieve Sustainable Ageing Societies
 Pekka Orpana (Ambassador-designate of Finland to Japan)

Session 1: Health Innovation for Age Friendly Communities
Thought Starters:
 Kazumi Nishikawa (Director of Healthcare Industries Division, Commerce and Service Industry Policy Group, Ministry of Economy, Trade and Industry (METI))
 Gail Kohn (Coordinator, Age-Friendly DC)
 Paul McGarry (Head, Greater Manchester Ageing Hub, Greater Manchester Combined Authority)
 Kenji Shuto (Vice Governor, Kanagawa Prefecture)
 Marco Ivancic (International Operations Lead, Home Instead Senior Care)

Session 2: 21st Century Health Policy for Super Ageing Societies
Thought Starters:
 Masami Sakoi (Assistant Minister, Health Policy Bureau, Ministry of Health, Labour and Welfare (MHLW))
 Brian Toohey (Senior Vice President of International Advocacy, Pharmaceutical Research and Manufacturers of America (PhRMA))
 Patrik Jonsson (President, Eli Lilly Japan; Chairman of Japan Based Executive Committee, PhRMA)
 David P. Ryan (General Manager, Health & Life Sciences Sector, Internet of Things Group, Intel Corporation)
 Hiroaki Miyata (Professor of Health Policy and Management, School of Medicine, Keio University)

Session 3: Financing Super Ageing Societies
Thought Starters:
 Kazumasa Oguro (Professor, Faculty of Economics, Hosei University)
 Akihisa Harada (President & Representative Director, Pfizer Japan Inc.)
 Takaoh Miyagawa (Senior Leader, Corporate Management, AEGON Sony Life Insurance Co., Ltd.)

Roundtable Participants:
 Masatomi Akana (Corporate Officer and Vice President of Corporate Affairs, Eisai Co., Ltd.)
 Sarah Louise Barber (Director, WHO Kobe Centre)
 David Gossack (Vice President for Asia, U.S. Chamber of Commerce)
 Akihisa Harada (President & Representative Director, Pfizer Japan Inc.)
 Yuko Harayama (Former Executive Member of the Council for Science and Technology Policy at the Cabinet Office of Japan)
 Nicholas Hill (Minister Counselor for Economic Affairs, U.S. Embassy Tokyo)
 Lyo Inuyama (Operating Officer and Head of Medical Affairs, Bayer Yakuhin, Ltd.)
 Marco Ivancic (International Operations Lead, Home Instead Senior Care)
 Michael W. Hodin (CEO, GCOA)
 Patrik Jonsson (President, Eli Lilly Japan; Chairman of Japan Based Executive Committee, PhRMA)
 Isao Kamae (Project Professor, Graduate School of Public Policy, The University of Tokyo)
 Mitsunobu R Kano (Professor and Vice Executive Director, Okayama University)
 Gail Kohn (Coordinator, Age-Friendly DC)
 Kiyoshi Kurokawa (Chairman, HGPI)
 Yukihiro Matsuyama (Research Director, Canon Institute for Global Studies)
 Paul McGarry (Head, Greater Manchester Ageing Hub, Greater Manchester Combined Authority)
 Takaoh Miyagawa (Senior Leader, Corporate Management, AEGON Sony Life Insurance Co., Ltd.)
 Hiroaki Miyata (Professor of Health Policy and Management, School of Medicine, Keio University)
 Toshihiko Morita (Director for Planning, Planning Division, Office of the Governor for Policy Planning, Tokyo Metropolitan Government)
 Shinsuke Muto (President, Tetsuyu Institute Medical Corporation)
 Kazumi Nishikawa (Director of Healthcare Industries Division, Commerce and Service Industry Policy Group, Ministry of Economy, Trade and Industry (METI))
 Ryoji Noritake (CEO, Board Member, HGPI)
 Kazumasa Oguro (Professor, Faculty of Economics, Hosei University)
 Kanoko Oishi (CEO, Mediva Inc.)
 Pekka Orpana (Ambassador-designate of Finland to Japan)
 Melinda M. Pavek (Science, Innovation and Development Unit Chief, Economic and Scientific Affairs, U.S. Embassy Tokyo)
 David P. Ryan (General Manager, Health & Life Sciences Sector, Internet of Things Group, Intel Corporation)
 Masami Sakoi (Assistant Minister, Health Policy Bureau, Ministry of Health, Labour and Welfare (MHLW))
 Jiro Seguchi (Head of Asia Pacific Global Corporate & Investment Banking Country Executive for Japan Bank of America Group)
 Kenji Shibuya (Professor and Chair, Department of Global Health Policy, Graduate School of Medicine, University of Tokyo)
 Kenji Shuto (Vice Governor, Kanagawa Prefectural Government)
 Keisuke Suzuki (State Minister of Finance, Government of Japan)
 Brian C. Toohey (Senior Vice President for International Advocacy, PhRMA)

(titles omitted)
(Photographed by: Kazunori Izawa)